Krishna, B. Madhu
Garg, Pankaj
Kulkarni, Prakash
Horne, David
Salgia, Ravi
Singhal, Sharad S. https://orcid.org/0000-0002-6415-8160
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-22-1-0331)
Article History
Received: 7 June 2025
Accepted: 28 June 2025
First Online: 12 July 2025
Declarations
:
: Human participants were not part of this study. The research involving animals followed IACUC protocol #22011, which gained approval from the City of Hope Animal Care and Ethics Committee.
: Not applicable.
: We demonstrate that RLIP is essential for ovarian cancer formation, its expression is significantly higher in ovarian cancer cells than in non-malignant cells, and its depletion or inhibition prevents ovarian carcinogenesis and metastases.
: The authors declare no competing interests.